2025 ADA Standards of Care Update: The Different Faces of Diabetes
September 5, 2025
Honolulu, HI
Activity description: Learners in attendance will receive a comprehensive update on the latest in diabetes care and management by dissecting the 2025 ADA diabetes standards of care interspersed with the latest pharmacologic interventions using a case study approach. In addition, learners will learn how to recognize the different types of diabetes, including; type 1, type 2, LADA, GDM, Type 3c, Type 3, MODY and Ketosis Prone Type 2 and the clinical significance of each.
Target audience: This activity is designed for individuals or groups of diabetes care and education specialists including Nurses, Dietitians, Pharmacists, PAs, Social Workers, and other health care providers interested in staying up to date on current practices of care for people with diabetes and other related conditions.
Requirements for successful completion: For successful completion, participants are required to attend the full activity, and complete and submit the program evaluation at the conclusion of the educational event. Your Statement of Credit will be issued upon submission of the evaluation form. Pharmacists must provide their date of birth (MMDD) and NABP ePID to receive credit. Pharmacist learners who fail to provide this information will not receive credit for this activity. Please check your NABP profile within 45 days of this activity to make sure your credits were uploaded. Per the American Academy of Nurse Practitioners Certification Board, nurse practitioners are eligible to claim continuing education contact hours from ANCC
Disclosure and Mitigation of Relevant Conflicts of Interest: In accordance with the ACCME Standards for Integrity and Independence, the Association of Diabetes Care & Education Specialists (ADCES) requires anyone in a position to affect or control continuing education content (e.g., authors, presenters, and program planners) to disclose all financial relationships with ineligible companies. It is the responsibility of ADCES to mitigate and disclose all relevant conflicts of interest. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of the presentation.
Relevant disclosures (or lack thereof) among education activity planners and faculty are as follows:
All identified relevant conflicts of interest have been mitigated.
Speakers
Beverly Thomassian, RN, MPH, CDCES, BC-ADM – has no relevant financial relationships with ineligible companies
Alan Parsa, MD – Novo Nordisk: Speakers Bureau
Planners
Camlyn Masuda, PharmD, CDCES, BCACP– has no relevant financial relationships with ineligible companies
Naomi Fukuda, MSN, APRN, BC-ADM, CDCES – has no relevant financial relationships with ineligible companies
Kourtney Inouye, MS, RDN, CDCES, LD – has no relevant financial relationships with ineligible companies
Viola Genadio, APRN, CDCES, BC-ADM – has no relevant financial relationships with ineligible companies
Patrick Uyemoto, PharmD, MBA – Novo Nordisk: Employment
Jessica Taylor Spurrier, DNP MS MSN-APHN RN CDCES – has no relevant financial relationships with ineligible companies
Kevin Kam, RPh, CDCES – Abbott Diabetes: Speakers Bureau; tandem Diabetes, Insulet: Certified Pump Trainer
Content Reviewers
Catherine Moring, PhD, RD, BC-ADM, CDCES, MCHES – has no relevant financial relationships with ineligible companies
Anand Patel, PharmD, BCP – has no relevant financial relationships with ineligible companies
Jocelyn Protopappas, MSW, MPH, RDN – has no relevant financial relationships with ineligible companies
Marlene Schiferle, MSN, RD, CDCES – has no relevant financial relationships with ineligible companies
Bau Tran, PA-C, PharmD – has no relevant financial relationships with ineligible companies
Activity Agenda
Agenda:
08:00 – 9:40 am Updates to the ADA Standards of Care- Beverly Thomassian
09:40 am – 10:10 am Break and visit exhibitors
10:10 am – 11:50 am Identify the key elements of the standards that improve clinical care for people with diabetes - Beverly Thomassian
11:50 am – 1:00 pm Lunch and visit exhibitors
1:00 pm – 2:05 pm Discuss the diagnosis and symptoms of the different types of immune mediated diabetes - Beverly Thomassian
2:05 pm – 2:25 pm Break and visit exhibitors
2:25 pm – 3:30 pm Describe clinical manifestations of type 2, GDM, type 3, type 3c and MODY - Beverly Thomassian
3:30 pm – 4:30 pm Practical approaches to treat these different types of diabetes presentations in clinical care – Dr. Alan Parsa
Registration Link:
Contact: Naomi Fukuda, [email protected]
CEU: 6.5 hours for physicians, nurses, pharmacists, physician assistants, dieticians and social workers
Objectives:
- State 3 changes and updates to the annual ADA Standards of Medical Care in Diabetes.
- List at least one key element of the discussed standards that improve clinical care for people with diabetes.
- Describe strategies to use the ADA hyperglycemia algorithm to determine appropriate use of the latest medications that address hyperglycemia and cardiorenal health.
- Discuss the diagnosis and symptoms of the different types of immune mediated diabetes.
- Describe clinical manifestations of type 2, GDM, type 3, type 3c and MODY.
- Share practical approaches to treat these different types of diabetes presentations in clinical care.